Comparative assessment of quality of life in patients receiving intraperitoneal aerosol chemotherapy under pressure for gastric cancer with peritoneal dissemination
Journal of Clinical Practice · 18.06.2026 · 17 (2) · 22-34
DOI: 10.17816/clinpract700069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Practice, online erschienen am 18.06.2026. Verfasst von Sergei A. Klimin und 6 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: Gastric cancer with peritoneal dissemination remains a clinical challenge requiring innovative approaches to preserve quality of life. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) represents a minimally invasive method of local treatment; however, its impact on quality of life compared with standard systemic polychemotherapy (sPCT) has not been sufficiently studied. AIM: To assess and compare quality of life in patients with stage IV gastric cancer and peritoneal dissemination receiving sPCT versus combined treatment (sPCT+PIPAC). METHODS: A prospective randomized study (protocol NCT06313801) enrolled 72 patients: 39 in the sPCT group and 33 in the sPCT+PIPAC group. Quality of life (QOL) was assessed using the standardized EORTC QLQ-C30 questionnaire at five time points: before treatment, after 3 and 6 courses, and 3 and 6 months after completion of treatment. Analysis was performed using multivariate analysis of variance with repeated measures. Changes in QOL were presented using an error bar plot. RESULTS: At baseline, groups had comparable indicators (p=0.297). Statistically significant differences in favor of the sPCT+PIPAC group were detected from the third to fifth measurement (QOL3: p=0.009; QOL4: p=0.006; QOL5: p=0.031). Similar results were obtained in the subgroup with positive peritoneal lavage without macroscopic carcinomatosis (Cy+) (QOL3: p=0.005; QOL4: p=0.015; QOL5: p=0.013). In subgroups with macroscopic peritoneal dissemination (PCI 1-7 and PCI 8-15), no statistically significant differences were detected (p 0.24 and p 0.18). CONCLUSION: Addition of PIPAC to sPCT in patients with positive peritoneal lavage leads to a statistically significant improvement in quality of life indicators. In patients with macroscopic peritoneal carcinomatosis, addition of PIPAC does not worsen quality of life compared with sPCT. TRANSLATE with x English Arabic Hebrew Polish Bulgarian Hindi Portuguese Catalan Hmong Daw Romanian Chinese Simplified Hungarian Russian Chinese Traditional Indonesian Slovak Czech Italian Slovenian Danish Japanese Spanish Dutch Klingon Swedish English Korean Thai Estonian Latvian Turkish Finnish Lithuanian Ukrainian French Malay Urdu German Maltese Vietnamese Greek Norwegian Welsh Haitian Creole Persian TRANSLATE with COPY THE URL BELOW Back EMBED THE SNIPPET BELOW IN YOUR SITE Enable collaborative features and customize widget: Bing Webmaster Portal Back
Zitieren
APA
Klimin, S. A., Kolesnik, Y. I., Mustafaeva, S. E., Kiselev, N. M., Shumskaya, I. S., Zagainov, V. E., & Gamayunov, S. V. (2026). Comparative assessment of quality of life in patients receiving intraperitoneal aerosol chemotherapy under pressure for gastric cancer with peritoneal dissemination. Journal of Clinical Practice, 17(2), 22-34. https://doi.org/10.17816/clinpract700069
Vancouver
Klimin SA, Kolesnik YI, Mustafaeva SE, Kiselev NM, Shumskaya IS, Zagainov VE, et al. Comparative assessment of quality of life in patients receiving intraperitoneal aerosol chemotherapy under pressure for gastric cancer with peritoneal dissemination. Journal of Clinical Practice. 2026;17(2):22-34. doi:10.17816/clinpract700069
BibTeX
@article{Klimin2026,
author = {Klimin, Sergei A. and Kolesnik, Yan I. and Mustafaeva, Shamama E. and Kiselev, Nikolai M. and Shumskaya, Irina S. and Zagainov, Vladimir E. and Gamayunov, Sergey V.},
title = {Comparative assessment of quality of life in patients receiving intraperitoneal aerosol chemotherapy under pressure for gastric cancer with peritoneal dissemination},
journal = {Journal of Clinical Practice},
year = {2026},
volume = {17},
number = {2},
pages = {22--34},
doi = {10.17816/clinpract700069}
}
EUVIMED